Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool

Detalles Bibliográficos
Autores principales: Weber, Sabine, Benesic, Andreas, Ishigami, Masatoshi, Gerbes, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527692/
https://www.ncbi.nlm.nih.gov/pubmed/33024923
http://dx.doi.org/10.1002/hep4.1565
_version_ 1783589110845276160
author Weber, Sabine
Benesic, Andreas
Ishigami, Masatoshi
Gerbes, Alexander L.
author_facet Weber, Sabine
Benesic, Andreas
Ishigami, Masatoshi
Gerbes, Alexander L.
author_sort Weber, Sabine
collection PubMed
description
format Online
Article
Text
id pubmed-7527692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75276922020-10-05 Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool Weber, Sabine Benesic, Andreas Ishigami, Masatoshi Gerbes, Alexander L. Hepatol Commun Correspondence John Wiley and Sons Inc. 2020-08-28 /pmc/articles/PMC7527692/ /pubmed/33024923 http://dx.doi.org/10.1002/hep4.1565 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Correspondence
Weber, Sabine
Benesic, Andreas
Ishigami, Masatoshi
Gerbes, Alexander L.
Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title_full Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title_fullStr Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title_full_unstemmed Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title_short Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool
title_sort drug‐induced liver injury by checkpoint inhibitors: benefit of a causality assessment tool
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527692/
https://www.ncbi.nlm.nih.gov/pubmed/33024923
http://dx.doi.org/10.1002/hep4.1565
work_keys_str_mv AT webersabine druginducedliverinjurybycheckpointinhibitorsbenefitofacausalityassessmenttool
AT benesicandreas druginducedliverinjurybycheckpointinhibitorsbenefitofacausalityassessmenttool
AT ishigamimasatoshi druginducedliverinjurybycheckpointinhibitorsbenefitofacausalityassessmenttool
AT gerbesalexanderl druginducedliverinjurybycheckpointinhibitorsbenefitofacausalityassessmenttool

Ejemplares similares